Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DNLI | AMGN | VRTX | REGN | BMY |
| Company | Denali Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 20.39 | 314.82 | 430.93 | 988.00 | 45.00 |
| High | 20.75 | 320.15 | 437.42 | 988.96 | 45.17 |
| Low | 20.05 | 312.87 | 428.62 | 966.34 | 44.66 |
| Last | 20.27 | 320.71 | 437.84 | 976.63 | 44.77 |
| Change | +0.52 | +9.30 | +9.25 | -8.01 | +0.06 |
| % Change | +2.63% | +2.99% | +2.16% | -0.81% | +0.13% |
| Volume | 328,333 | 1,146,481 | 359,276 | 273,718 | 3,807,822 |
| 20-Day Average Volume | 1,160,898 | 2,847,352 | 1,070,828 | 447,051 | 13,925,447 |
| Previous Close | 19.75 | 311.41 | 428.59 | 984.64 | 44.71 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 17.05 | 288.80 | 407.43 | 930.81 | 45.50 |
| 20-Day Raw Stochastic | 90.95% | 94.33% | 97.82% | 81.92% | 22.27% |
| 20-Day Relative Strength | 60.46% | 68.86% | 68.28% | 58.01% | 36.41% |
| Weighted Alpha | -28.78 | +42.91 | +29.32 | +28.30 | -32.84 |
| Today's Opinion | 8% Buy | 72% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 8% Sell | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 56% Sell | 40% Sell | 24% Buy | 24% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.83% since 05/08/24 | +3.83% since 05/08/24 | +4.06% since 05/08/24 | +1.32% since 05/08/24 | +2.40% since 05/08/24 |
| Low | 18.27 on 05/10/24 | 306.32 on 05/09/24 | 416.03 on 05/09/24 | 956.76 on 05/09/24 | 43.49 on 05/09/24 |
| High | 20.75 on 05/15/24 | 319.10 on 05/15/24 | 436.84 on 05/15/24 | 988.96 on 05/15/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | +13.17% since 04/15/24 | +20.18% since 04/15/24 | +9.68% since 04/15/24 | +7.77% since 04/15/24 | -7.81% since 04/15/24 |
| Low | 14.56 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 20.75 on 05/15/24 | 322.60 on 05/03/24 | 436.84 on 05/15/24 | 988.96 on 05/15/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | +9.97% since 02/15/24 | +10.39% since 02/15/24 | +2.24% since 02/15/24 | +1.43% since 02/15/24 | -9.55% since 02/15/24 |
| Low | 14.56 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 23.52 on 02/27/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +9.25% since 11/15/23 | +16.87% since 11/15/23 | +24.76% since 11/15/23 | +22.21% since 11/15/23 | -13.28% since 11/15/23 |
| Low | 14.56 on 04/25/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 785.83 on 11/16/23 | 43.33 on 05/02/24 |
| High | 23.81 on 12/15/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,816,528 | 167,051,216 | 110,598,944 | 108,493,528 | 90,631,640 |
| Shares Outstanding, K | 142,609 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 330,530,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -145,220,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -119,470,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 1.39 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.68 on 05/07/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/13/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.56 | 28.55 | 26.33 | 42.91 |